Skip to main content

Advertisement

SpringerLink
Log in

Adiponectin is down-regulated in bone marrow interstitial fluid in hematological malignancy

  • Original Article
  • Published:
International Journal of Hematology Aims and scope Submit manuscript

Abstract

Adipokines play a role in carcinogenesis in a variety of malignancies. These findings were established with regard to serum adipokines and malignancies. However, the expression of adipokines in bone marrow fluid remains unclear, and an investigation of the correlation between bone marrow adipokines and hematological malignancy is needed. The present study was designed to detect adipokine concentrations, including adiponectin, leptin and resistin, in bone marrow interstitial fluid from patients with hematological malignancy and controlled counterparts. The correlations between adipokines, body mass index, clinical parameters, and hematological malignancy were assessed. A total of 80 bone marrow samples were assessed for values of adipokines, adiponectin, leptin and resistin. Patients with hematological malignancy had lower levels of adiponectin. Adiponectin from leukemia bone marrow expressed significantly low values. The adiponectin levels were inversely correlated with body mass index. In conclusion, adiponectin was decreased in bone marrow from patients with leukemia and negatively correlated with body mass index.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults. N Engl J Med. 2003;348(17):1625–38.

    Article  PubMed  Google Scholar 

  2. Pramanik R, Sheng X, Ichihara B, Heisterkamp N, Mittelman SD. Adipose tissue attracts and protects acute lymphoblastic leukemia cells from chemotherapy. Leuk Res. 2013;37:503–9. doi:10.1016/j.leukres.2012.12.013.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  3. Calle EE, Kaaks R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer. 2004;4(8):579–91. doi:10.1038/nrc1408.

    Article  CAS  PubMed  Google Scholar 

  4. Samanic C, Gridley G, Chow WH, Lubin J, Hoover RN, Fraumeni JF Jr. Obesity and cancer risk among white and black United States veterans. Cancer Causes Control. 2004;15(1):35–43.

    Article  PubMed  Google Scholar 

  5. Castillo Jorge J, Reagan JL, Randall R, Ingham EA. Obesity but not overweight increases the incidence and mortality of leukemia in adults: a meta-analysis of prospective cohort studies. Leuk Res. 2012;36:868–75. doi:10.1016/j.leukres.2011.12.020.

    Article  PubMed  Google Scholar 

  6. Melin J, Khandekar MJ, Cohen P, Spiegelman BM. Molecular mechanisms of cancer development in obesity. Nat Rev Cancer. 2011;11:886–95. doi:10.1038/nrc3174.

    Article  Google Scholar 

  7. Kuo CH, Chen KF, Chou SH, Huang YF, Wu CY, Cheng DE, et al. Lung tumor-associated dendritic cell-derived resistin promoted cancer progression by increasing Wolf-Hirschhorn syndrome candidate 1/twist pathway. Carcinogenesis. 2013;34(11):2600–9.

    Article  CAS  PubMed  Google Scholar 

  8. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun. 1999;257(1):79–83.

    Article  CAS  PubMed  Google Scholar 

  9. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature. 1994;372(6505):425–32.

    Article  CAS  PubMed  Google Scholar 

  10. Garofalo C, Surmacz E. Leptin and Cancer. J Cell Physiol. 2006;207:12–22. doi:10.1002/jcp.20472.

    Article  CAS  PubMed  Google Scholar 

  11. Kishida K, Funahashi T, Shimomura I. Adiponectin as a routine clinical biomarker. Best Pract Res Clin Endocrinol Metab. 2014;28:119–30. doi:10.1016/j.beem.2013.08.006.

    Article  CAS  PubMed  Google Scholar 

  12. Otani K, Kitayama J, Yasuda K. Adiponectin suppresses tumorigenesis in Apc(Min/+) mice. Cancer Lett. 2010;288:177–82. doi:10.1016/j.canlet.2009.06.037.

    Article  CAS  PubMed  Google Scholar 

  13. Al-Suhaimi EA, Shehzad A. Leptin, resistin and visfatin: the missing link between endocrine metabolic disorders and immunity. Eur J Med Res. 2013;18:12.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  14. Filková M, Haluzík M, Gay S, Šenolt L. The role of resistin as a regulator of inflammation: implications for various human pathologies. Clin Immunol. 2009;133:157–70. doi:10.1016/j.clim.2009.07.013.

    Article  PubMed  Google Scholar 

  15. Yilmaz M, Kis C, Ceylan NO. Serum leptin level in acute myeloid leukeia patients. Hematology. 2008;13:21–3. doi:10.1179/102453308X315771.

    Article  CAS  PubMed  Google Scholar 

  16. Caers J, Deleu S, Belaid Z. Neighboring adipocytes participate in the bone marrow microenvironment of multiple myeloma cells. Leukemia. 2007;21:1580–4. doi:10.1038/sj.leu.2404658.

    Article  CAS  PubMed  Google Scholar 

  17. Yokota T, Oritani K, Takahashi I. Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. Blood. 2000;96:1723–32.

    CAS  PubMed  Google Scholar 

  18. Medina EA, Oberheu K, Polusani SR, Ortega V, Velagaleti GVN, Oyajobi BO. PKA/AMPK signaling in relation to adiponectin’s antiproliferative effect on multiple myeloma cells. Leukemia. 2014;28(10):2080–9. doi:10.1038/leu.2014.112.

    Article  CAS  PubMed  Google Scholar 

  19. Park J, Sherer PE. Leptin and cancer: from cancer stem cells to metastasis. Endocr Relat Cancer. 2011;18:C25–9. doi:10.1530/ERC-11-0163.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  20. Karapanagiotou EM, Tsochatzis EM, Dilana KD, Tourkantonis I, Gratsias I, Syrigos KN. The Significance of leptin, adiponectin, and resistin serum levels in non-small cell lung cancer (NSCLC). Lung Cancer. 2008;61:391–7. doi:10.1016/j.lungcan.2008.01.018.

    Article  PubMed  Google Scholar 

  21. Pamuk GE, Demir M, Harmandar F, Yeşil Y, Turgut B, Vural Ö. Leptin and resistin levels in serum of patients with hematologic malignancies: correlation with clinical characteristics. Exp Oncol. 2006;28(3):241–4.

    CAS  PubMed  Google Scholar 

  22. Konopleva M, Mikhail A, Estrov Z. Expression and function of leptin receptor isoforms in myeloid leukemia and myelodysplastic syndromes: proliferative and anti-apoptotic activities. Blood. 1999;93(5):1668–76.

    CAS  PubMed  Google Scholar 

  23. Hino M, Nakao T, Yamane T, Ohta K, Takubo T, Tatsumi N. Leptin receptor and leukemia. Leukemia and Lymphoma. 2000;36:457–61.

    Article  CAS  PubMed  Google Scholar 

  24. Nakao T, Hino M, Yamane T, Nishizawa Y, Morii H, Tatsumi N. Expression of the leptin receptor in human leukaemic blast cells. Br J Haematol. 1998;102:740–5.

    Article  CAS  PubMed  Google Scholar 

  25. Ana Maria Pino SR. Concentration of adipogenic and proinflammatory cytokines in the bone marrow supernatant fluid of osteoporotic women. J Bone Miner Res. 2010;25(3):492–8. doi:10.1359/jbmr.090802.

    Article  PubMed  Google Scholar 

  26. Adamczak M, Rzepka E, Chudek J, Wiecek A. Ageing and plasma adiponectin concentration in apparently healthy males and females. Clin Endocrinol (Oxf). 2005;62(1):114–8.

    Article  CAS  PubMed  Google Scholar 

  27. Obata Y, Yamada Y, Takahi Y. Relationship between serum adiponectin levels and age in healthy subjects and patients with type 2 diabetes. Clin Endocrinol (Oxf). 2013;79(2):204–10. doi:10.1111/cen.12041.

    Article  CAS  Google Scholar 

  28. Isidori AM, Strollo F, More M, Caprio M, Aversa A, Moretti C, et al. Leptin and aging: correlation with endocrine changes in male and female healthy adult populations of different body weights. J Clin Endocrinol Metab. 2000;85(5):1954–62.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Author notes

    Authors and Affiliations

    1. Department of Internal Medicine, Chi-Mei Medical Center, Yong Kang, Tainan, Taiwan

      Fan-Yu Lin, Hung-Chang Wu, Kuo-Chen Cheng & Yin-Hsun Feng

    2. Division of Hematology and Oncology, Department of Internal Medicine, Chi-Mei Medical Center, Yong Kang, 901 Chung-Hwa Road, Tainan, 71004, Taiwan

      Hung-Chang Wu, Chao-Ling Tung, Chi-Pei Chang & Yin-Hsun Feng

    3. Department of Safety Health and Environmental Engineering, Chung Hwa University of Medical Technology, Tainan, Taiwan

      Kuo-Chen Cheng

    4. Department of Nursing, Chung Hwa University of Medical Technology, Tainan, Taiwan

      Yin-Hsun Feng

    Authors
    1. Fan-Yu Lin
      View author publications

      You can also search for this author in PubMed Google Scholar

    2. Hung-Chang Wu
      View author publications

      You can also search for this author in PubMed Google Scholar

    3. Kuo-Chen Cheng
      View author publications

      You can also search for this author in PubMed Google Scholar

    4. Chao-Ling Tung
      View author publications

      You can also search for this author in PubMed Google Scholar

    5. Chi-Pei Chang
      View author publications

      You can also search for this author in PubMed Google Scholar

    6. Yin-Hsun Feng
      View author publications

      You can also search for this author in PubMed Google Scholar

    Corresponding author

    Correspondence to Yin-Hsun Feng.

    Ethics declarations

    Conflict of interest

    All authors declared no conflict of interest.

    Additional information

    F.-Y. Lin and H.-C. Wu equally contributed to this work.

    About this article

    Check for updates. Verify currency and authenticity via CrossMark

    Cite this article

    Lin, FY., Wu, HC., Cheng, KC. et al. Adiponectin is down-regulated in bone marrow interstitial fluid in hematological malignancy. Int J Hematol 102, 312–317 (2015). https://doi.org/10.1007/s12185-015-1831-z

    Download citation

    • Received:

    • Revised:

    • Accepted:

    • Published:

    • Issue Date:

    • DOI: https://doi.org/10.1007/s12185-015-1831-z

    Keywords

    Search

    Navigation